New Alzheimer’s Drug Aduhelm Stirs Hope, Controversy
Judy Owens knows all about the uproar surrounding the Food and Drug Administration’s approval of the first new Alzheimer’s drug to be introduced in nearly two decades — and she’s fine with it. Her husband, Tony, was diagnosed with the devastating disease in 2010 at age 60. He had participated in two previous clinical trials […]
